Cell, method and kit for conducting an assay for neutralizing antibodies

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9969801
SERIAL NO

12921110

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides a cell for use in a one-step cell-based assay for an extracellular ligand (e.g., IFNα) that initiates a ligand-specific signal at the nucleus of the cell and for neutralizing antibodies against the extracellular ligand. The cell-based one-step assay allows both the extracellular ligand concentration and the neutralizing antibody titer to be quantified in a single sample (e.g., serum) without the need for sample dilution and addition of exogenous extracellular ligand.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BIOMONITOR APSC/O ACCOUNTOR DENMARK (CRV-NO 27 42 10 83) HERLEV HOVEGADE 195 HERLEV 2730

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Lallemand, Christophe Paris, FR 11 29
Tovey, Michael Paris, FR 9 28

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Nov 15, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 15, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00